Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2025 Dispatch for the CV Team

L.A. McKeown

December 23, 2025

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

Presentation ESC 2024

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

Presenter: David Erlinge

September 02, 2024

News Daily News

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

Yael L. Maxwell

January 10, 2024

News Conference News AHA 2022

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

Shelley Wood

November 06, 2022

News Daily News

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

L.A. McKeown

November 30, 2021

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

News Daily News

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

Caitlin E. Cox

October 05, 2021

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

News Daily News

FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina

Caitlin E. Cox

August 03, 2020

News Conference News EuroPCR 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

Caitlin E. Cox

June 26, 2020

News Daily News

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Shelley Wood

January 11, 2019

News Daily News

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

L.A. McKeown

November 29, 2018

Advertisement

December 2025 Dispatch for the CV Team

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

INFINITY-SWEDEHEART: Percutaneous coronary intervention with a Bioadaptor compared to a contemporary Drug-eluting Stent (DES) in a large broad clinical population

No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm

BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI

SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

SWEDEHEART Data Reassure on 10-Year Survival for TAVI Patients With Pacemakers

Observational Study Supports Continuing Oral Anticoagulation During PCI

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

FFR Deferral of Nonculprit Lesions Riskier in ACS vs Stable Angina

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

None of the Usual Suspects? Troponin Elevation Still Warrants Attention

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content